Christopher Gast

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

Raffael Nachbagauer, Jodi Feser, Abdollah Naficy et al. · Nature Medicine · 2020 · 342 citations · Full text

Vaccination, Cross-protection, Vaccine Development +10

The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study

Pierre Van Damme, Ilse De Coster, Ananda S Bandyopadhyay et al. · The Lancet · 2019 · 143 citations · Full text

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

David I. Bernstein, Jeffrey T. Guptill, Abdollah Naficy et al. · The Lancet Infectious Diseases · 2019 · 138 citations · Full text

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials

Ilse De Coster, Isabel Leroux‐Roels, Ananda S Bandyopadhyay et al. · The Lancet · 2020 · 84 citations · Full text

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials

Xavier Sáez‐Llorens, Ananda S Bandyopadhyay, Christopher Gast et al. · The Lancet · 2020 · 77 citations · Full text